NDA Group, a regulatory affairs consultancy group, has named Dr Werner Van den Eynde as its new vice president, it was announced yesterday.

The new vice president is to lead the company's advisory board providing advice to pharmaceutical clients. He has held senior positions for companies such as GE Healthcare, Abbott and Solvay Pharmaceuticals.

In his new role, Dr Van den Eynde will manage strategy operations and development of the NDA advisory board, including business development, sales, marketing and service development.